6.4(top 2%)
Impact Factor
6.9(top 2%)
extended IF
93(top 4%)
citing journals
citing authors

Most Cited Articles of Expert Opinion on Therapeutic Targets

Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy2012531
Targeting the EGFR signaling pathway in cancer therapy2012512
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches2012472
Targeting selectins and selectin ligands in inflammation and cancer2007283
The IL-6/sIL-6R complex as a novel target for therapeutic approaches2007278
The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy2010263
STAT proteins as novel targets for cancer drug discovery2004233
Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase2012222
Targeting the dopamine D2 receptor in schizophrenia2006219
Cathepsin B as a cancer target2013216
The role of dopamine in motivation for food in humans: implications for obesity2002196
The paraventricular nucleus of the hypothalamus - a potential target for integrative treatment of autonomic dysfunction2008189
The 5-HT3 receptor as a therapeutic target2007185
From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer2006178
MERS-CoV spike protein: a key target for antivirals2017176
Emerging strategies for EphA2 receptor targeting for cancer therapeutics2011175
Inhibiting the transcription factor HSF1 as an anticancer strategy2009174
Wnt signaling as a therapeutic target for bone diseases2009171
Tyrosine kinases as targets in cancer therapy - successes and failures2003171
Targeting the Bcl-2 family for cancer therapy2013168
Targeting the HGF/Met signaling pathway in cancer therapy2012162
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders2011160
Overcoming drug resistance in pancreatic cancer2011157
Targeting the PI3K signaling pathway in cancer therapy2012156
Bacterial, fungal and protozoan carbonic anhydrases as drug targets2015153